Preclinical applications and studies
-
Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study
4/17/2025
This randomized controlled pivotal phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for 3 consecutive weeks pre-surgery.
-
LC-MS/MS Method Development Of Endogenous Small Molecule Biomarker
1/17/2025
Biomarkers are essential to improve drug R&D efficiency. Explore some practical solutions for achieving a fit-for-purpose LC-MS/MS biomarker analysis method.
-
Drug Development Program Management
10/28/2024
Learn how a consultant helped a biotech company specializing in immuno-oncology to develop timeline reports for the product and portfolio and identify and address gaps in the filing plan.
-
A Versatile Application For Rapid Mass Confirmation And Purity Assessment Of Biotherapeutics
7/18/2022
We explore a streamlined integrated workflow for data acquisition, processing and reporting of deconvoluted mass data for biotherapeutics, deployable in regulated and non-regulated environments.
-
Transferring N-Glycan HILIC Separations Between UPLC And HPLC
7/18/2022
We demonstrate that comparable chromatographic profiles and relative quantitation can be achieved with the larger particle size column at HPLC-compatible pressures, albeit with an increase in sample load, mobile phase use, and most importantly, analysis time.
-
Improving Released N-glycan Analysis In Biotherapeutic Development Using Premier Solution With HPS Technology
7/12/2022
Explore how we improved releasing N-glycan analysis in biotherapeutic development, which can help develop robust and unbiased glycan assays for biotherapeutic development, manufacture, and release.
-
Method Migration Of Size-Exclusion And Ion- Exchange Methods For Monoclonal Antibody Analysis
7/12/2022
Discover how combining this system with modern UHPLC columns could make data more accurately interpreted through greater efficiency, selectivity, and enhanced resolution.
-
Rapid Size Variant Analysis of Monoclonal Antibodies Using SEC Columns
7/9/2022
This study examines technological advancements in both the column hardware and packed particle chemistry of solution that provides extended column lifetimes when using physiological pH mobile phases.
-
ACQUITY And XBridge Premier Protein SEC 250 Å Columns: A New Benchmark In Inert SEC Column Design
7/5/2022
We demonstrate the performance of a new column technology designed to provide a holistic solution to the problems of undesired secondary interactions in SEC.
-
Performance Stability Of CORTECS 2.7 μm Columns Following Repeated Injections Of Precipitated Plasma
7/1/2022
We review a column made using optimally packed solid-core particles. These columns are designed to tolerate repeated injections of minimally processed samples, while maintaining assay performance.